2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow KHK4083: new trials by email Literature Review of KHK4083 trials Research Report on KHK4083
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis KHK4083, Placebo - Atopic Dermatitis | Phase 2 | Completed | Kyowa Kirin, Inc. | 274 | 2018-10-22 | 2024-04-26 |
| Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis KHK4083, Placebo - Ulcerative Colitis, Digestive System Diseases | Phase 2 | Completed | Kyowa Kirin, Inc. | 66 | 2016-06-01 | 2024-04-26 |
Abdominal Pain (1) · Autoimmune Diseases (1) · Colitis (1) · Colitis, Ulcerative (1) · Colonic Diseases (1) · Dermatitis, Atopic (1) · Digestive System Diseases (1) · Eczema (1) · Gastrointestinal Diseases (1) · Inflammatory Bowel Diseases (1) · Intestinal Diseases (1) · Skin Diseases (1)
United States (2) · Canada (1) · Czechia (1) · Germany (1) · Hungary (1) · Japan (1) · Poland (1) · Romania (1) · Russia (1) · Serbia (1)
Ehsanollah Esfandiari, MD, PhD (1) · Vincent Strout, MBA (1)